BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El-Sharkawy A, Al Zaidan L, Malki A. Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis. Front Oncol 2018;8:265. [PMID: 30116721 DOI: 10.3389/fonc.2018.00265] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Li QW, Qiu B, Hu WM, Guo SP, Wu YJ, Zhu YJ, Hu N, Ai XL, Chen NB, Guo JY, Hu YH, Liu MZ, Zeng MS, Liu H. Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I-III Pulmonary Lymphoepithelioma-Like Carcinoma. Front Oncol 2020;10:1487. [PMID: 32974179 DOI: 10.3389/fonc.2020.01487] [Reference Citation Analysis]
2 Wojtak K, Perales-Puchalt A, Weiner DB. Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein-Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth. Vaccines (Basel) 2019;7:E44. [PMID: 31137606 DOI: 10.3390/vaccines7020044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
3 Ferreira DA, Tayyar Y, Idris A, McMillan NAJ. A "hit-and-run" affair - A possible link for cancer progression in virally driven cancers. Biochim Biophys Acta Rev Cancer 2021;1875:188476. [PMID: 33186643 DOI: 10.1016/j.bbcan.2020.188476] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
4 Zaman S, Chobrutskiy BI, Patel JS, Diviney A, Tu YN, Tong WL, Gill T, Blanck G. Antiviral T Cell Receptor Complementarity Determining Region-3 Sequences Are Associated with a Worse Cancer Outcome: A Pancancer Analysis. Viral Immunol 2020;33:404-12. [PMID: 32315578 DOI: 10.1089/vim.2019.0156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ghabeshi S, Najafi A, Zamani B, Soltani M, Arero AG, Izadi S, Piroozmand A. Evaluation of molecular apoptosis signaling pathways and its correlation with EBV viral load in SLE patients using systems biology approach. Hum Antibodies 2021. [PMID: 34864653 DOI: 10.3233/HAB-211505] [Reference Citation Analysis]
6 Hassani A, Khan G. Epstein-Barr Virus and miRNAs: Partners in Crime in the Pathogenesis of Multiple Sclerosis? Front Immunol 2019;10:695. [PMID: 31001286 DOI: 10.3389/fimmu.2019.00695] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ruggiero E, Richter SN. Viral G-quadruplexes: New frontiers in virus pathogenesis and antiviral therapy. Annu Rep Med Chem 2020;54:101-31. [PMID: 32427223 DOI: 10.1016/bs.armc.2020.04.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
8 Simoni Y, Becht E, Li S, Loh CY, Yeong JPS, Lim TKH, Takano A, Tan DSW, Newell EW. Partial absence of PD-1 expression by tumor-infiltrating EBV-specific CD8+ T cells in EBV-driven lymphoepithelioma-like carcinoma. Clin Transl Immunology 2020;9:e1175. [PMID: 32995000 DOI: 10.1002/cti2.1175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Trompet E, Temblador A, Gillemot S, Topalis D, Snoeck R, Andrei G. An MHV-68 Mutator Phenotype Mutant Virus, Confirmed by CRISPR/Cas9-Mediated Gene Editing of the Viral DNA Polymerase Gene, Shows Reduced Viral Fitness. Viruses 2021;13:985. [PMID: 34073189 DOI: 10.3390/v13060985] [Reference Citation Analysis]
10 Zhu QY, Zhao GX, Li Y, Talakatta G, Mai HQ, Le QT, Young LS, Zeng MS. Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma. MedComm (2020) 2021;2:175-206. [PMID: 34766141 DOI: 10.1002/mco2.32] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ewald PW, Swain Ewald HA. The scope of viral causation of human cancers: interpreting virus density from an evolutionary perspective. Philos Trans R Soc Lond B Biol Sci 2019;374:20180304. [PMID: 30955500 DOI: 10.1098/rstb.2018.0304] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chen Q, Feng J, Wu J, Yu Z, Zhang W, Chen Y, Yao P, Zhang H. HKDC1 C-terminal based peptides inhibit extranodal natural killer/T-cell lymphoma by modulation of mitochondrial function and EBV suppression. Leukemia 2020;34:2736-48. [PMID: 32203147 DOI: 10.1038/s41375-020-0801-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Almeida JFM, Proenca-Modena JL, Bufalo NE, Peres KC, de Souza Teixeira E, Teodoro L, Beck RM, Moraes AP, Tincani AJ, Arns CW, Ward LS. Epstein-Barr virus induces morphological and molecular changes in thyroid neoplastic cells. Endocrine 2020;69:321-30. [PMID: 32166585 DOI: 10.1007/s12020-020-02253-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Manivannan AC, Devaraju V, Velmurugan P, Sathiamoorthi T, Sivakumar S, Subbiah SK, Ravi AV. Tumorigenesis and diagnostic practice applied in two oncogenic viruses: Epstein Barr virus and T-cell lymphotropic virus-1-Mini review. Biomed Pharmacother 2021;142:111974. [PMID: 34343895 DOI: 10.1016/j.biopha.2021.111974] [Reference Citation Analysis]
15 Trompet E, Topalis D, Gillemot S, Snoeck R, Andrei G. Viral fitness of MHV-68 viruses harboring drug resistance mutations in the protein kinase or thymidine kinase. Antiviral Res 2020;182:104901. [PMID: 32763314 DOI: 10.1016/j.antiviral.2020.104901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Higuchi T, Matsuo K, Hashida Y, Kitahata K, Ujihara T, Taniguchi A, Yoshie O, Nakayama T, Daibata M. Epstein-Barr virus-positive pyothorax-associated lymphoma expresses CCL17 and CCL22 chemokines that attract CCR4-expressing regulatory T cells. Cancer Lett 2019;453:184-92. [PMID: 30953706 DOI: 10.1016/j.canlet.2019.03.053] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
17 Wu RWK, Chu ESM, Yuen JWM, Huang Z. Comparative study of FosPeg® photodynamic effect on nasopharyngeal carcinoma cells in 2D and 3D models. J Photochem Photobiol B 2020;210:111987. [PMID: 32801063 DOI: 10.1016/j.jphotobiol.2020.111987] [Reference Citation Analysis]
18 Francies FZ, Dlamini Z. Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies. Cells 2021;10:239. [PMID: 33530521 DOI: 10.3390/cells10020239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Nagel S, Uphoff CC, Dirks WG, Pommerenke C, Meyer C, Drexler HG. Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL. PLoS One 2019;14:e0216898. [PMID: 31141539 DOI: 10.1371/journal.pone.0216898] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
20 Notarte KI, Senanayake S, Macaranas I, Albano PM, Mundo L, Fennell E, Leoncini L, Murray P. MicroRNA and Other Non-Coding RNAs in Epstein-Barr Virus-Associated Cancers. Cancers (Basel) 2021;13:3909. [PMID: 34359809 DOI: 10.3390/cancers13153909] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Zhang H, Lu J, Jiao Y, Chen Q, Li M, Wang Z, Yu Z, Huang X, Yao A, Gao Q, Xie W, Li L, Yao P. Aspirin Inhibits Natural Killer/T-Cell Lymphoma by Modulation of VEGF Expression and Mitochondrial Function. Front Oncol 2018;8:679. [PMID: 30693272 DOI: 10.3389/fonc.2018.00679] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
22 Bogolyubova AV. Human Oncogenic Viruses: Old Facts and New Hypotheses. Mol Biol 2019;53:767-75. [DOI: 10.1134/s0026893319050030] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Charostad J, Nakhaie M, Dehghani A, Faghihloo E. The interplay between EBV and KSHV viral products and NF-κB pathway in oncogenesis. Infect Agent Cancer 2020;15:62. [PMID: 33072180 DOI: 10.1186/s13027-020-00317-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Zhang SQ, Pan SM, Liang SX, Han YS, Chen HB, Li JC. Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review). Int J Oncol 2021;58:9. [PMID: 33649830 DOI: 10.3892/ijo.2021.5188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
25 Jiang Y, Ding Y, Liu S, Luo B. The role of Epstein–Barr virus-encoded latent membrane proteins in host immune escape. Future Virology 2021;16:565-76. [DOI: 10.2217/fvl-2020-0320] [Reference Citation Analysis]
26 Chulpanova DS, Solovyeva VV, Kitaeva KV, Dunham SP, Khaiboullina SF, Rizvanov AA. Recombinant Viruses for Cancer Therapy. Biomedicines 2018;6:E94. [PMID: 30257488 DOI: 10.3390/biomedicines6040094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
27 Monferrer E, Sanegre S, Vieco-Martí I, López-Carrasco A, Fariñas F, Villatoro A, Abanades S, Mañes S, de la Cruz-Merino L, Noguera R, Álvaro Naranjo T. Immunometabolism Modulation in Therapy. Biomedicines 2021;9:798. [PMID: 34356862 DOI: 10.3390/biomedicines9070798] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Zheng J, Shi Y, Feng Z, Zheng Y, Li Z, Zhao Y, Wang Y. Oncogenic effects of exosomes in γ‐herpesvirus‐associated neoplasms. J Cell Physiol 2019;234:19167-79. [DOI: 10.1002/jcp.28573] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
29 Liang Z, Wang L, Wu H, Singh D, Zhang X. Integrative analysis of microRNA and mRNA expression profiles in MARC-145 cells infected with PRRSV. Virus Genes 2020;56:610-20. [PMID: 32785889 DOI: 10.1007/s11262-020-01786-w] [Reference Citation Analysis]
30 Chaiwongkot A, Kitkumthorn N, Srisuttee R, Buranapraditkun S. Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines. Biomed Rep 2020;13:43. [PMID: 32934816 DOI: 10.3892/br.2020.1350] [Reference Citation Analysis]
31 Pietropaolo V, Prezioso C, Moens U. Role of Virus-Induced Host Cell Epigenetic Changes in Cancer. Int J Mol Sci 2021;22:8346. [PMID: 34361112 DOI: 10.3390/ijms22158346] [Reference Citation Analysis]
32 Re V, Brisotto G, Repetto O, De Zorzi M, Caggiari L, Zanussi S, Alessandrini L, Canzonieri V, Miolo G, Puglisi F, Belluco C, Steffan A, Cannizzaro R. Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options. Int J Mol Sci 2020;21:E9400. [PMID: 33321820 DOI: 10.3390/ijms21249400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Germini D, Sall FB, Shmakova A, Wiels J, Dokudovskaya S, Drouet E, Vassetzky Y. Oncogenic Properties of the EBV ZEBRA Protein. Cancers (Basel) 2020;12:E1479. [PMID: 32517128 DOI: 10.3390/cancers12061479] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]